FIRST SOLAR Q4 FY25 earnings call FSLR

The policy and trade environment in 2025 remained complex, with ongoing uncertainties from budgetary reconciliation, tariff scenarios, and regulatory developments like Section 232 actions, FEOC restrictions, and AD/CVD investigations. The Trump administration's withdrawal of its appeal against the U.S. Court of International Trade ruling on retroactive AD/CVD tariffs could lead to significant financial impact for foreign producers. Interim Treasury guidance on FEOC restrictions and Commerce's preliminary CVD determinations (81% Laos, 126% India, 104% Indonesia) are seen as favorable for domestic manufacturing, with final AD/CVD rates expected by September. First Solar also filed a petition with the ITC against 10 foreign manufacturers for TOPCon patent infringement, separate from existing monetary damage lawsuits.

First Solar's technology strategy focuses on optimizing efficiency, energy yield, and cost through thin-film expertise. The CuRe semiconductor platform, following limited commercial production, demonstrated expected advantaged energy profiles and is set for a disciplined factory-by-factory conversion rollout, starting with the Ohio Series 6 factory in Q1 2026. This aims to enhance energy attributes like temperature coefficient and degradation rate. In parallel, the perovskite thin film program is advancing, with a dedicated development line in Ohio reaching full in-line processing in Q3 2025. The company initiated sourcing for a perovskite Series 6 module form factor pilot line, expected to be operational in early 2027, and entered a licensing agreement with Oxford PV for perovskite-related patents.

Growth continued in 2025 with the initiation of commercial production at the Louisiana factory, First Solar's fifth U.S. facility. Plans were also announced to onshore Series 6 module finishing with a new facility in South Carolina, expected to begin production in Q4 2026 and ramp through H1 2027. Despite these expansions, international Series 6 facilities in Malaysia and Vietnam are running at low utilization rates (around 20%) due to demand constraints and strategic curtailment. This underutilization is viewed as an option to capitalize on potential future demand catalysts, with some tools from Southeast Asia being repurposed for the U.S. finishing line.

First Solar reported strong financial results for FY25, including net sales of $5.2 billion and diluted EPS of $14.21, alongside a robust cash position of $2.9 billion gross cash and $2.4 billion net cash. The company monetized $1.4 billion of 2025 Section 45X tax credits and received $118 million for 2024 credits via direct pay. A new $1.5 billion senior unsecured revolving credit facility was secured to enhance financial flexibility. Capital allocation priorities include maintaining a $1.5 billion to $2 billion working capital reserve, funding growth and technology replication, investing in R&D and strategic enablers, and evaluating M&A, with share repurchases considered later in the year pending policy clarity and bookings.

The company ended 2025 with a contracted backlog of 50.1 gigawatts valued at $15 billion, down from 68.5 gigawatts ($20.5 billion) at the end of 2024 due to 8.3 gigawatts of debookings. First Solar maintained a disciplined and selective approach to customer contracting, capitalizing on demand that recognizes the differentiated value of its product. Recent U.S. utility scale bookings achieved an ASP of $0.364 per watt, inclusive of adjusters, reflecting the value of domestic content and CuRe attributes. The 2026 global ASP is forecast at approximately $0.287 per watt, with U.S. ASP around $0.308 per watt, reflecting limited CuRe upside this year due to contractual notification timing.

India production is assumed to be sold into the domestic market at full capacity, with strong demand and high-teens to low-20s gross margins despite lower ASPs, due to significantly lower manufacturing costs. The company plans to implement CuRe technology in India starting early 2027. While there's a risk of overcapacity from domestic panel ramping, the evolving Approved List of Models and Manufacturers (ALMM) requirements for cells and wafers are seen as advantageous for First Solar's vertically integrated manufacturing. The company will continue to evaluate rerouting some India volume to the U.S. market if tariff dynamics are favorable.